| Daunorubicin | Approved Investigational | GPX1 | 2876 |
upregulated | Daunorubicin results in increased expression of GPX1 mRNA | 3p21.31 | |
| Daunorubicin | Approved Investigational | HRC | 3270 |
downregulated | Daunorubicin results in decreased expression of HRC mRNA | 19q13.33 | |
| Daunorubicin | Approved Investigational | IRX4 | 50805 |
downregulated | Daunorubicin results in decreased expression of IRX4 mRNA | 5p15.33 | |
| Daunorubicin | Approved Investigational | JAK2 | 3717 |
downregulated | Daunorubicin results in decreased expression of JAK2 mRNA | 9p24.1 | |
| Daunorubicin | Approved Investigational | KCNH2 | 3757 |
downregulated | Daunorubicin results in decreased expression of KCNH2 mRNA | 7q36.1 | |
| Daunorubicin | Approved Investigational | KCNJ2 | 3759 |
upregulated | Daunorubicin results in increased expression of KCNJ2 mRNA | 17q24.3 | |
| Daunorubicin | Approved Investigational | KCNQ1 | 3784 |
downregulated | Daunorubicin results in decreased expression of KCNQ1 mRNA | 11p15.5-p15.4 | |
| Daunorubicin | Approved Investigational | LDB3 | 11155 |
downregulated | Daunorubicin results in decreased expression of LDB3 mRNA | 10q23.2 | |
| Daunorubicin | Approved Investigational | MAP2K3 | 5606 |
upregulated | Daunorubicin results in increased expression of MAP2K3 mRNA | 17p11.2 | |
| Daunorubicin | Approved Investigational | MAP3K5 | 4217 |
downregulated | Daunorubicin results in decreased expression of MAP3K5 mRNA | 6q23.3 | |
| Daunorubicin | Approved Investigational | MAPT | 4137 |
downregulated | Daunorubicin results in decreased expression of MAPT mRNA | 17q21.31 | |
| Daunorubicin | Approved Investigational | MDM4 | 4194 |
downregulated | Daunorubicin results in decreased expression of MDM4 mRNA | 1q32.1 | |
| Daunorubicin | Approved Investigational | MYH6 | 4624 |
downregulated | Daunorubicin results in decreased expression of MYH6 mRNA | 14q11.2 | |
| Daunorubicin | Approved Investigational | MYH7 | 4625 |
downregulated | Daunorubicin results in decreased expression of MYH7 mRNA | 14q11.2 | |
| Daunorubicin | Approved Investigational | MYOM2 | 9172 |
downregulated | Daunorubicin results in decreased expression of MYOM2 mRNA | 8p23.3 | |
| Daunorubicin | Approved Investigational | NCK2 | 8440 |
downregulated | Daunorubicin results in decreased expression of NCK2 mRNA | 2q12.2 | |
| Daunorubicin | Approved Investigational | NQO1 | 1728 |
downregulated | Daunorubicin results in decreased expression of NQO1 mRNA | 16q22.1 | |
| Daunorubicin | Approved Investigational | NRAP | 4892 |
downregulated | Daunorubicin results in decreased expression of NRAP mRNA | 10q25.3 | |
| Daunorubicin | Approved Investigational | NRAS | 4893 |
upregulated | Daunorubicin results in increased expression of NRAS mRNA | 1p13.2 | |
| Daunorubicin | Approved Investigational | PLK3 | 1263 |
upregulated | Daunorubicin results in increased expression of PLK3 mRNA | 1p34.1 | |
| Daunorubicin | Approved Investigational | PPP1R3A | 5506 |
downregulated | Daunorubicin results in decreased expression of PPP1R3A mRNA | 7q31.1 | |
| Daunorubicin | Approved Investigational | PRC1 | 9055 |
downregulated | Daunorubicin results in decreased expression of PRC1 mRNA | 15q26.1 | |
| Daunorubicin | Approved Investigational | PRDM16 | 63976 |
downregulated | Daunorubicin results in decreased expression of PRDM16 mRNA | 1p36.32 | |
| Daunorubicin | Approved Investigational | PRKX | 5613 |
upregulated | Daunorubicin results in increased expression of PRKX mRNA | Xp22.33 | |
| Daunorubicin | Approved Investigational | PYGM | 5837 |
downregulated | Daunorubicin results in decreased expression of PYGM mRNA | 11q13.1 | |